InvestorsHub Logo

IonStock

11/05/20 5:57 AM

#29552 RE: mikar #29548

Safety was already established mos. ago at the 1st DMC review. This 2nd DMC review affirms the likely "statistically significant" efficacy (read: success) of Aviptadil in this trial, which we serious investors have all been waiting for.